About Us

Sonoran Biosciences is a privately held specialty pharmaceutical company developing sustained release formulations for acute care indications. Sonoran’s products are based on its proprietary SB Gel, an injectable carrier that forms a solid gel in the body, releases drugs over multiple days, and dissolves after the drugs are released. Sonoran’s lead products are SBG004, a long-acting formulation of bupivacaine, and SBG003, a fixed-dose combination of tobramycin and vancomycin for prevention of surgical site infection.